Bacovsky, J., Minarik, J., Langova, K., Ordeltova, M., Zemanova, M., Pika, T., & Scudla, V. Thalidomide and bortezomib overcome the prognostic significance of proliferative index in multiple myeloma.
Chicago Style (17th ed.) CitationBacovsky, J., J. Minarik, K. Langova, M. Ordeltova, M. Zemanova, T. Pika, and V. Scudla. Thalidomide and Bortezomib Overcome the Prognostic Significance of Proliferative Index in Multiple Myeloma.
MLA (9th ed.) CitationBacovsky, J., et al. Thalidomide and Bortezomib Overcome the Prognostic Significance of Proliferative Index in Multiple Myeloma.
Warning: These citations may not always be 100% accurate.
